International Prenatal Infection Prevention Month 2026: Make prevention guidance consistent, timely, and usable across the pregnancy journey

A pregnant adult and support person meet with a prenatal clinician, with The Healthcare Executive logo aligned above the International Prenatal Infection Prevention Month 2026 title.
Greg Wahlstrom, MBA, HCM
A pregnant adult and support person meet with a prenatal clinician, with The Healthcare Executive logo aligned above the International Prenatal Infection Prevention Month 2026 title.
February 1 to 28, 2026 · Executive Brief

International Prenatal Infection Prevention Month 2026

Make prevention guidance consistent, timely, and usable across the pregnancy journey.

The 2026 leadership signal

Prenatal infection prevention is a continuity test.

International Prenatal Infection Prevention Month brings attention to infections that can affect a pregnant person, a developing baby, or a newborn. The conditions grouped under that umbrella differ in transmission, timing, prevention, testing, and treatment. A single generic checklist cannot safely replace condition-specific clinical guidance.

The system opportunity is to make accurate information arrive at the right point in the journey. Preconception vaccination review, food and environmental guidance, prenatal screening, exposure response, treatment, delivery planning, and newborn follow-up often sit in different teams and systems. Reliability depends on how those steps connect.

Communication also matters. Prevention language must avoid blame, explain uncertainty, distinguish routine education from urgent symptoms, and respect the words people use for themselves. The goal is informed partnership with a clinician, not self-diagnosis or a promise that every adverse outcome can be avoided.

Executive priority

Create one governed prenatal infection pathway that connects education, recommended testing, exposure response, treatment, delivery information, and newborn follow-up.

System route

Place each prevention step where it can be acted on.

A strong route uses approved guidance, respects clinical judgment, and prevents the patient from becoming the only carrier of critical information.

  1. Prepare before and early in pregnancy

    Include vaccination history, current medications, medical conditions, travel or environmental concerns, and infection history in preconception or early prenatal review. Route questions that require individualized advice to a clinician.

  2. Educate without overload

    Deliver short, stage-appropriate guidance on food safety, hand hygiene, relevant exposures, sexually transmitted infections, and other prevention steps. Make materials understandable, accessible, and available in the person's preferred language.

  3. Test at the right time

    Embed current screening recommendations and local protocols into prenatal workflows. A test order should lead to result review, patient communication, treatment when indicated, and any required partner or public health action.

  4. Respond to symptoms or exposure

    Provide a visible route for a reported fever, rash exposure, foodborne illness concern, STI concern, or other relevant change. Use clinician-approved triage rather than a broad automated reassurance message.

  5. Carry the plan through birth

    Make relevant infection status, treatment, intrapartum needs, pending results, and newborn follow-up visible to the delivery and pediatric teams while protecting privacy.

Reliability rule: Use condition-specific sources for clinical content. Campaign materials can support awareness, but they should not replace CDC guidance, professional standards, local protocols, or individualized medical advice.

Operating dashboard

Measure the reliability of the route, not the reach of the reminder.

The dashboard should trace recommended actions from eligibility through completion and show where communication or access breaks down.

01

Early review

Track completion of the organization's approved infection-related history and education elements at the appropriate early prenatal touchpoint.

MeasureEligible patients with timely documented review
02

Screening completion

Measure eligible screening from order through specimen collection and resulted status, using current clinical criteria.

MeasureEligible screening completed in the approved window
03

Result closure

Confirm that actionable results are reviewed, communicated, and connected to the next appropriate care step.

MeasureActionable results with closed-loop follow-up
04

Delivery continuity

Audit whether relevant prenatal infection information and plans are available to the delivery and newborn teams when needed.

MeasureDelivery records with complete indicated infection plan
05

Access and equity

Review completion and delays by language, geography, payer, entry to care, and other locally appropriate access factors.

MeasureLargest material gap in pathway completion
Warm handoff

Keep infection information moving with the care plan.

The highest-risk gaps often appear between teams, especially when a result arrives after a visit or care shifts to another facility.

Prenatal lane

Education and screening to clinical action

  1. Identify the recommended action and its timing using current guidance.
  2. Assign result review and patient communication to a named role.
  3. Document treatment, monitoring, or no further action with the clinical rationale.
Exposure lane

Reported concern to individualized assessment

  1. Capture timing, symptoms, relevant exposure details, and pregnancy stage without asking the patient to determine the diagnosis.
  2. Route the concern to the appropriate clinician under an approved urgency standard.
  3. Give understandable next steps and a clear escalation route for worsening symptoms.
Birth lane

Prenatal team to delivery and newborn teams

  1. Transfer relevant results, treatment, pending tests, and intrapartum requirements.
  2. Confirm the receiving team can see the current plan before delivery when feasible.
  3. Assign newborn testing, observation, treatment, or follow-up tasks when clinically indicated.

Protect sensitive information and disclose only what is permitted and necessary for care. Do not require the pregnant person to repeat private details across avoidable handoffs.

Executive scorecard

Questions for a safer prenatal infection pathway.

Each measure needs a clinical definition, an accountable owner, and a process for reviewing missed opportunities without blame.

Use stable definitions and stratify results by site, population, and service line when appropriate.
Signal Executive question Accountable owner Review cadence
Guidance Are patient education and clinical workflows aligned with current authoritative guidance? Obstetric clinical governance Quarterly and on guidance change
Screening Which recommended prenatal infection screenings are most often late or incomplete, and why? Prenatal operations Monthly
Results Do actionable results reach the patient and the next care step within the approved interval? Clinical quality Monthly exception review
Continuity Can delivery and newborn teams see relevant results, treatment, and pending actions? Perinatal service line Monthly audit
Respect Do materials avoid blame, reflect uncertainty, and meet language and accessibility needs? Patient education and experience Semiannual review
90-day plan

Build continuity into prenatal infection prevention.

Choose one care journey, such as early prenatal intake through delivery, and use real missed handoffs to guide the design.

Days 1 to 30

Govern and map

  • Confirm the authoritative guidance and clinical owner for each included infection workflow.
  • Map education, testing, result review, exposure calls, delivery transfer, and newborn follow-up.
  • Review materials for plain language, accessibility, cultural respect, and non-blaming language.
Days 31 to 60

Pilot the closed loop

  • Pilot a result-closure queue with explicit ownership and escalation.
  • Test an exposure-response script that routes clinical questions without over-reassurance.
  • Audit delivery records for missing infection plans and pending results.
Days 61 to 90

Standardize and learn

  • Publish the approved pathway and role-based training.
  • Launch the five-measure dashboard and review missed opportunities without blame.
  • Set a process for updating workflows and patient materials when authoritative guidance changes.

Prevention becomes safer when continuity is designed.

People need accurate, timely guidance and a care team that owns the next step. Leaders can strengthen that experience without overstating certainty or placing responsibility for every infection outcome on the patient.

Leadership actionTrace ten recent prenatal infection results from order to communication, treatment or resolution, delivery visibility, and newborn follow-up. Fix the first recurring break.

Authoritative resources

Safety note: Not every prenatal infection is preventable, and infection is not a person's fault. Guidance varies by infection, pregnancy stage, exposure, symptoms, and clinical history. People who are pregnant or planning pregnancy should discuss vaccination, testing, medications, exposures, and symptoms with a qualified clinician. Fever, severe illness, reduced fetal movement, labor concerns, or another urgent change requires prompt assessment under local guidance.

The organizer confirms February and the official observance name. No distinct formal 2026 theme was published on the organizer's campaign page.

Leave us a Comment